Effects of HIV protease inhibitors on barrier function in the human intestinal cell line HT-29/B6.
Bode
H
H
Department of Gastroenterology/Infectious Diseases, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, 12200 Berlin, Germany. bode@medizin.fu-berlin.de
Schmidt
W
W
Schulzke
J D
JD
Fromm
M
M
Riecken
E O
EO
Ullrich
R
R
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D003106:Colon / Q000166:cytology; D003967:Diarrhea / Q000139:chemically induced / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D019073:HT29 Cells; D006801:Humans; D019469:Indinavir / Q000494:pharmacology; D007408:Intestinal Absorption / Q000187:drug effects* / Q000502:physiology; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism*; D019888:Nelfinavir / Q000494:pharmacology; D019438:Ritonavir / Q000494:pharmacology; D019258:Saquinavir / Q000494:pharmacology*
D017320:HIV Protease Inhibitors; D019469:Indinavir; D019888:Nelfinavir; D019258:Saquinavir; D019438:Ritonavir